Villitis of unknown etiology is associated with a distinct pattern of chemokine up-regulation in the feto-maternal and placental compartments: Implications for conjoint maternal allograft rejection and maternal anti-fetal graft-versus-host disease

Journal of Immunology

Volumn 182, Issue 6, 2009, Pages 3919-3927

  Kim, Mi Jeong ^a,b   Romero, Roberto ^a,b,c   Kim, Chong Jai ^a,b,c   Tarca, Adi L ^a,b,c,d   Chhauy, Sovantha ^a,b   LaJeunesse, Christopher ^a,b   Lee, Deug Chan ^a,b   Draghici, Sorin ^d   Gotsch, Francesca ^a,b   Kusanovic, Juan Pedro ^a,b,c   Hassan, Sonia S ^a,b,c   Kim, Jung Sun ^a,b,c  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b HUTZEL HOSPITAL   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Wayne State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD86 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; CXCL11 CHEMOKINE; CXCL13 CHEMOKINE; CXCL9 CHEMOKINE; DECTIN 1; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HLA C ANTIGEN; HLA DP ANTIGEN; HLA DPA1 ANTIGEN; HLA DPB1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 21 RECEPTOR; INTERLEUKIN 23P19; LCP2 PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; PROTEIN; PROTEIN KINASE LCK; PTPRC PROTEIN; RAC2 PROTEIN; RANTES; SLAMF7 PROTEIN; SOD2 PROTEIN; STAT1 PROTEIN; TRANSCRIPTOME; UNCLASSIFIED DRUG; AUTACOID; CHEMOKINE RECEPTOR;

ARTICLE; BLOOD CELL; CHORIOAMNIONITIS; CLINICAL ARTICLE; FEMALE; FETOPLACENTAL UNIT; FETUS; FETUS CIRCULATION; GENE EXPRESSION; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INFLAMMATION; MATERNAL PLASMA; MOTHER; PLACENTA; PLACENTA DISORDER; PLACENTA VILLUS; PRIORITY JOURNAL; RNA ANALYSIS; UPREGULATION; VILLITIS OF UNKNOWN ETIOLOGY; BIOSYNTHESIS; BLOOD; CHORION VILLUS; DNA MICROARRAY; FETOMATERNAL TRANSFUSION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; PREGNANCY; SIGNAL TRANSDUCTION;

CHEMOKINES; CHORIOAMNIONITIS; CHORIONIC VILLI; FEMALE; FETUS; GENE EXPRESSION PROFILING; GRAFT REJECTION; GRAFT VS HOST DISEASE; HUMANS; INFLAMMATION MEDIATORS; MATERNAL-FETAL EXCHANGE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLACENTA DISEASES; PREGNANCY; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 65449161749     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803834     Document Type: Article

References (54)

1. Kraus, F. T., R. W. Redline, D. J. Gersell, D. M. Nelson, and J. M. Diche. 2004. Inflammation and infection. In Placental Pathology Atlas of Non Tumor Pathology 3. F. T. Kraus, R. W. Redline, D. J. Gersell, D. M. Nelson, and J. M. Diche, eds. Armed Forces Institute of Pathology, Washington, DC, pp. 75-116.
2. Gomez, R., R. Romero, F. Ghezzi, B. H. Yoon, M. Mazor, and S. M. Berry. 1998. The fetal inflammatory response syndrome. Am. J. Obstet. Gynecol. 179: 194-202.
3. Murtha, A. P., P. C. Greig, C. E. Jimmerson, B. Roitman-Johnson, J. Allen, and W. N. Herbert. 1996. Maternal serum interleukin-6 concentrations in patients with preterm premature rupture of membranes and evidence of infection. Am. J. Obstet. Gynecol. 175: 966-969.
4. Shimoya, K., N. Matsuzaki, T. Taniguchi, T. Okada, F. Saji, and Y. Murata. 1997. Interleukin-8 level in maternal serum as a marker for screening of histological chorioamnionitis at term. Int. J. Gynaecol. Obstet. 57: 153-159.
5. Brito, H., P. Juliano, C. Altemani, and A. Altemani. 2005. Is the immunohistochemical study of the inflammatory infiltrate helpful in distinguishing villitis of unknown etiology from non-specific infection villitis? Placenta 26: 839-841.
6. Kim, J. S., R. Romero, M. R. Kim, Y. M. Kim, L. Friel, J. Espinoza, and C. J. Kim. 2008. Involvement of Hofbauer cells and maternal T cells in villitis of unknown aetiology. Histopathology 52: 457-464.
7. Becroft, D. M., J. M. Thompson, and E. A. Mitchell. 2005. Placental villitis of unknown origin: epidemiologic associations. Am. J. Obstet. Gynecol. 192: 264-271.
8. Redline, R. W. 2007. Villitis of unknown etiology: noninfectious chronic villitis in the placenta. Hum. Pathol. 38: 1439-1446.
9. Boog, G. 2008. Chronic villitis of unknown etiology. Eur. J. Obstet. Gynecol. Reprod. Biol. 136: 9-15.
10. Labarrere, C. A., and W. P. Faulk. 1995. Maternal cells in chorionic villi from placentae of normal and abnormal human pregnancies. Am. J. Reprod. Immunol. 33: 54-59.
11. Redline, R. W., and P. Patterson. 1993. Villitis of unknown etiology is associated with major infiltration of fetal tissue by maternal inflammatory cells. Am. J. Pathol. 143: 473-479.
12. Myerson, D., R. K. Parkin, K. Benirschke, C. N. Tschetter, and S. R. Hyde. 2006. The pathogenesis of villitis of unknown etiology: analysis with a new conjoint immunohistochemistry-in situ hybridization procedure to identify specific maternal and fetal cells. Pediatr. Dev. Pathol. 9: 257-265.
13. Weniger, M., J. C. Engelmann, and J. Schultz. 2007. Genome Expression Pathway Analysis Tool: analysis and visualization of microarray gene expression data under genomic, proteomic and metabolic context. BMC Bioinformatics 8: 179.
14. Irizarry, R. A., B. Hobbs, F. Collin, Y. D. Beazer-Barclay, K. J. Antonellis, U. Scherf, and T. P. Speed. 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
15. Smyth, G. K. 2005. Limma: Linear Models for Microarray Data. Springer, New York.
16. Benjamini, Y., and Y. Hochberg. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57: 289-300.
17. Gentleman, R. 2004. Using GO for statistical analyses. In Compstat 2004 Proceedings in Computational Statistics. J. Antoch, ed. Springer, Prague, pp. 171-180.
18. Tarca, A. L., S. Draghici, P. Khatri, S. S. Hassan, P. Mittal, J. S. Kim, C. J. Kim, J. P. Kusanovic, and R. Romero. 2009. A novel signaling pathway impact analysis (SPIA). Bioinformatics 25: 75-82.
19. Draghici, S., P. Khatri, A. L. Tarca, K. Amin, A. Done, C. Voichita, C. Georgescu, and R. Romero. 2007. A systems biology approach for pathway level analysis. Genome Res. 17: 1537-1545.
20. Akalin, E., R. C. Hendrix, R. G. Polavarapu, T. C. Pearson, J. F. Neylan, C. P. Larsen, and F. G. Lakkis. 2001. Gene expression analysis in human renal allograft biopsy samples using high-density oligoarray technology. Transplantation 72: 948-953.
21. Deng, M. C., H. J. Eisen, M. R. Mehra, M. Billingham, C. C. Marboe, G. Berry, J. Kobashigawa, F. L. Johnson, R. C. Starling, S. Murali, et al. 2006. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am. J. Transplant. 6: 150-160.
22. Flechner, S. M., S. M. Kurian, S. R. Head, S. M. Sharp, T. C. Whisenant, J. Zhang, J. D. Chismar, S. Horvath, T. Mondala, T. Gilmartin, et al. 2004. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am. J. Transplant. 4: 1475-1489.
23. Gimino, V. J., J. D. Lande, T. R. Berryman, R. A. King, and M. I. Hertz. 2003. Gene expression profiling of bronchoalveolar lavage cells in acute lung rejection. Am. J. Respir. Crit. Care Med. 168: 1237-1242.
24. Ichiba, T., T. Teshima, R. Kuick, D. E. Misek, C. Liu, Y. Takada, Y. Maeda, P. Reddy, D. L. Williams, S. M. Hanash, and J. L. Ferrara. 2003. Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays. Blood 102: 763-771.
25. Sugerman, P. B., S. B. Faber, L. M. Willis, A. Petrovic, G. F. Murphy, J. Pappo, D. Silberstein, and M. R. van den Brink. 2004. Kinetics of gene expression in murine cutaneous graft-versus-host disease. Am. J. Pathol. 164: 2189-2202.
26. Labarrere, C. A., J. A. McIntyre, and W. P. Faulk. 1990. Immunohistologic evidence that villitis in human normal term placentas is an immunologic lesion. Am. J. Obstet. Gynecol. 162: 515-522.
27. Labarrere, C. A., and W. P. Faulk. 1990. MHC class II reactivity of human villous trophoblast in chronic inflammation of unestablished etiology. Transplantation 50: 812-816.
28. Favre, A., A. Cerri, A. Bacigalupo, E. Lanino, E. Berti, and C. E. Grossi. 1997. Immunohistochemical study of skin lesions in acute and chronic graft versus host disease following bone marrow transplantation. Am. J. Surg. Pathol. 21: 23-34.
29. Famulski, K. S., G. Einecke, J. Reeve, V. Ramassar, K. Allanach, T. Mueller, L. G. Hidalgo, L. F. Zhu, and P. F. Halloran. 2006. Changes in the transcriptome in allograft rejection: IFN-γ-induced transcripts in mouse kidney allografts. Am. J. Transplant. 6: 1342-1354.
30. Hubscher, S. G., D. H. Adams, and E. Elias. 1990. Changes in the expression of major histocompatibility complex class II antigens in liver allograft rejection. J. Pathol. 162: 165-171.
31. Goldstein, J., M. Braverman, C. Salafia, and P. Buckley. 1988. The phenotype of human placental macrophages and its variation with gestational age. Am. J. Pathol. 133: 648-659.
32. Sutton, L., M. Gadd, D. Y. Mason, and C. W. Redman. 1986. Cells bearing class II MHC antigens in the human placenta and amniochorion. Immunology 58: 23-29.
33. Panzer, U., R. R. Reinking, O. M. Steinmetz, G. Zahner, U. Sudbeck, S. Fehr, B. Pfalzer, A. Schneider, F. Thaiss, M. Mack, et al. 2004. CXCR3 and CCR5 positive T-cell recruitment in acute human renal allograft rejection. Transplantation 78: 1341-1350.
34. Tan, J., and G. Zhou. 2005. Chemokine receptors and transplantation. Cell. Mol. Immunol. 2: 343-349.
35. Zhao, D. X., Y. Hu, G. G. Miller, A. D. Luster, R. N. Mitchell, and P. Libby. 2002. Differential expression of the IFN-γ-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell α chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection. J. Immunol. 169: 1556-1560.
36. Wysocki, C. A., S. B. Burkett, A. Panoskaltsis-Mortari, S. L. Kirby, A. D. Luster, K. McKinnon, B. R. Blazar, and J. S. Serody. 2004. Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning. J. Immunol. 173: 845-854.
37. Wysocki, C. A., A. Panoskaltsis-Mortari, B. R. Blazar, and J. S. Serody. 2005. Leukocyte migration and graft-versus-host disease. Blood 105: 4191-4199.
38. Piper, K. P., C. Horlock, S. J. Curnow, J. Arrazi, S. Nicholls, P. Mahendra, C. Craddock, and P. A. Moss. 2007. CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantation. Blood 110: 3827-3832.
39. Di Carlo, E., T. D'Antuono, S. Contento, M. Di Nicola, E. Ballone, and C. Sorrentino. 2007. Quilty effect has the features of lymphoid neogenesis and shares CXCL13-CXCR5 pathway with recurrent acute cardiac rejections. Am. J. Transplant. 7: 201-210.
40. Steinmetz, O. M., U. Panzer, U. Kneissler, S. Harendza, M. Lipp, U. Helmchen, and R. A. Stahl. 2005. BCA-1/CXCL13 expression is associated with CXCR5-positive B-cell cluster formation in acute renal transplant rejection. Kidney Int. 67: 1616-1621.
41. Kapur, P., D. Rakheja, A. M. Gomez, J. Sheffield, P. Sanchez, and B. B. Rogers. 2004. Characterization of inflammation in syphilitic villitis and in villitis of unknown etiology. Pediatr. Dev. Pathol. 7: 453-458.
42. Jenh, C. H., M. A. Cox, W. Hipkin, T. Lu, C. Pugliese-Sivo, W. Gonsiorek, C. C. Chou, S. K. Narula, and P. J. Zavodny. 2001. Human B cell-attracting chemokine 1 (BCA-1; CXCL13) is an agonist for the human CXCR3 receptor. Cytokine 15: 113-121.
43. + CXC chemokine-induced angiogenic activity. J. Immunol. 165: 5269-5277.
44. Romagnani, P., L. Lasagni, F. Annunziato, M. Serio, and S. Romagnani. 2004. CXC chemokines: the regulatory link between inflammation and angiogenesis. Trends Immunol. 25: 201-209.
45. Romagnani, P., F. Annunziato, L. Lasagni, E. Lazzeri, C. Beltrame, M. Francalanci, M. Uguccioni, G. Galli, L. Cosmi, L. Maurenzig, et al. 2001. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J. Clin. Invest. 107: 53-63.
46. Spinetti, G., G. Camarda, G. Bernardini, S. Romano Di Peppe, M. C. Capogrossi, and M. Napolitano. 2001. The chemokine CXCL13 (BCA-1) inhibits FGF-2 effects on endothelial cells. Biochem. Biophys. Res. Commun. 289: 19-24.
47. Redline, R. W., I. Ariel, R. N. Baergen, D. J. Desa, F. T. Kraus, D. J. Roberts, and C. M. Sander. 2004. Fetal vascular obstructive lesions: nosology and reproducibility of placental reaction patterns. Pediatr. Dev. Pathol. 7: 443-452.
48. Kao, J., J. Kobashigawa, M. C. Fishbein, W. R. MacLellan, M. D. Burdick, J. A. Belperio, and R. M. Strieter. 2003. Elevated serum levels of the CXCR3 chemokine ITAC are associated with the development of transplant coronary artery disease. Circulation 107: 1958-1961.
49. Hall, J. M., P. Lingenfelter, S. L. Adams, D. Lasser, J. A. Hansen, and M. A. Bean. 1995. Detection of maternal cells in human umbilical cord blood using fluorescence in situ hybridization. Blood 86: 2829-2832.
50. Shlomchik, W. D. 2007. Graft-versus-host disease. Nat. Rev. Immunol. 7: 340-352.
51. Hill, G. R., and J. L. Ferrara. 2000. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 95: 2754-2759.
52. Xun, C. Q., J. S. Thompson, C. D. Jennings, S. A. Brown, and M. B. Widmer. 1994. Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice. Blood 83: 2360-2367.
53. Watson, A. L., and G. J. Burton. 1998. A microscopical study of wound repair in the human placenta. Microsc. Res. Tech. 42: 351-368.
54. Zhou, P., K. W. Hwang, D. Palucki, O. Kim, K. A. Newell, Y. X. Fu, and M. L. Alegre. 2003. Secondary lymphoid organs are important but not absolutely required for allograft responses. Am. J. Transplant. 3: 259-266.